Does not ontain TSCA C^| -2- DuPont AEMR 205-95 EVALUATION^)?

firft %R> _ TRADE SECRET DuPont-9057 Study Title H-25183: Static, Acute, 96-Hour Screening Test to Pimephales prometas Laboratory Project ED: DuPont-9057 A u t h o r : Alan Samel, M.S.

Kennenedoyf. tedCshtaypman asking that John Cook of DuPont be present in put together...i.e, dose and justified our reason addition to G.

As promised, please find below the clarifications for the Dupont delegation at the meeting on the PFAS restriction on March 28: 1.

July 31, 2002, letter from DuPont to WVDEP; 29.

TRADE SECRET DuPont-8861 AR226-3212 Study Title H-25134: Static, Acute, 96-Hour Screening Test to Oncorhynchus mykiss Laboratory Project ID: DuPont-8861 Author: Laurie D.

While DuPont does not believe that the information provided with this submittal is indicative of substantial risk, DuPont is providing this information in light of the Agency's continued interest in perfluorinated substances.

AR226-2357 Andrew S Hartten 02/20/2004 10:46 AM , To: Mark Houlday/AE/DuPont@DuPont cc: Subject: Re: Proposed Monitoring Locations-Need to Discuss Please print, thanks!

TRADE SECRET AR226-3167 DuPont-4725 Study Title H-24516: Static, Acute, 96-Hour Screening Test with Pimephales promelas Laboratory Project ID: DuPont-4725 AUTHOR: Robert A.

TRADE SECRET AR226-3191 DuPont-8838 Study Title H-24944: Static, Acute, 96-Hour Screening Test to Pimephales promelas Laboratory Project ID: DuPont-8838 Author: Laurie D.

Mud Run is not on DuPont property and is not being monitored.

Study Completion Date 24 November 2003 Testing Facility BioReliance ~~ 9630 Medical Center Drive Rockville, MD 20850 for E. 1. duPont de Nemours and Company DuPont Haskell Laboratory P.O.

TRADE SECRET Study Title H-24761: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Laboratory Project ED: DuPont-55^1 AR226-3190 DuPont-5591 A u t h o r : Carol Finlay, B .A .

DuPont-2922 -7 - Company Sanitized.

DuPont-2927 Hompany Sarflfead.